European VC Funds

Mubadala Capital’s Ventures platform stands out as a leading global investor, blending the strengths of Mubadala Investment Company with the agility of a venture capital firm. Focused on technology and healthcare sectors, Mubadala has made over 75 investments, including notable startups like Chroma Medicine, Recursion Pharmaceuticals, and Exscientia. Their strategy revolves around partnering with visionary founders to build enduring companies, leveraging Mubadala’s extensive resources and global scale. Geographically, Mubadala Ventures operates with a significant presence in technology hubs such as San Francisco, London, and Abu Dhabi, ensuring deep integration into the global innovation ecosystem. They emphasize Series A+ investments in the U.S. and Series B+ in Europe, providing substantial capital and strategic support to their portfolio companies. Mubadala's investment strategy is marked by a focus on capital preservation and downside protection, ensuring sustainable growth and returns. The fund typically invests in founder-led companies, with average check sizes tailored to the needs of each growth stage. They are known for their disciplined approach to evaluating opportunities, benefiting from Mubadala's broad network and sovereign backing. The team at Mubadala Ventures includes industry veterans like Ibrahim Ajami, Head of Ventures, and Alaa Halawa, Co-Head of US Ventures. Their expertise spans various sectors and geographies, further strengthening Mubadala’s investment acumen. Startups looking to engage with Mubadala are advised to highlight their alignment with Mubadala’s strategic focus and demonstrate robust business models that can benefit from Mubadala’s vast resources and network.

Mucker Capital, founded in 2012 and headquartered in Los Angeles, is a venture capital firm that invests in seed and early-stage startups across the United States, Canada, and beyond. With additional offices in Austin and Toronto, Mucker Capital focuses on internet-enabled software and services, aiming to support startups outside the traditional Silicon Valley ecosystem. The firm believes that great companies can be built anywhere and provides tactical help, networking opportunities, and a bridge to Silicon Valley resources. Notable portfolio companies include Honey, acquired by PayPal; Surf Air, which went public on NASDAQ; and ServiceTitan, a business management software for home service providers. Mucker Capital has also backed companies like The Black Tux, ServiceTitan, and BloomNation. MuckerLab, their pre-seed accelerator, is highly regarded and ranked second in the U.S. by the Seed Accelerator Rankings Project based on valuations, exits, fundraising, survival, and founder satisfaction. Mucker Capital's approach includes rolling up their sleeves to work alongside entrepreneurs on product development, marketing, sales, recruiting, and other critical areas to help startups succeed. The firm has launched multiple funds, including Mucker III, a $45 million seed-stage fund, and continues to support the growth and scaling of innovative startups.

Munich Re, founded in 1880, is one of the world's leading providers of reinsurance, primary insurance, and risk management solutions. Headquartered in Munich, Germany, the company operates globally, offering comprehensive risk assessment and financial protection across a wide range of sectors. Munich Re has consistently ranked at the top of the global reinsurance industry, thanks to its robust risk management practices, financial stability, and innovative approach to emerging risks. The company’s strategy, known as Ambition 2025, focuses on three core pillars: Scale, Shape, and Succeed. This strategy aims to enhance Munich Re's core business, develop new digital and innovative business models, and deliver added value to shareholders, clients, employees, and communities. The company is particularly focused on expanding its reinsurance operations, modernizing IT infrastructure, and pushing the boundaries of digital solutions, including cybersecurity and the Internet of Things (IoT). In terms of financial performance, Munich Re reported a consolidated result of €4.6 billion for 2023, with a solvency ratio of 267%, reflecting its financial strength and stability. The company is also committed to sustainability, setting ambitious goals to decarbonize its operations and investment portfolio, with the aim of achieving net-zero emissions by 2050. Munich Re’s global presence is supported by over 42,800 employees across more than 50 countries, making it a critical player in managing complex and extraordinary risks worldwide​.

Munich Venture Partners (MVP) is a European venture capital firm that supports innovative tech companies driving the eco-industrial revolution. Founded in 2004 and based in Munich, Germany, MVP focuses on transformative technologies that promote decarbonization and digitalization in high-emission sectors. The firm invests in early to growth-stage companies, providing strategic support and leveraging its extensive network to help startups scale and succeed globally. The MVP team, led by founders and partners Walter Grassl, Rolf Nagel, and Michael Sailer, combines deep expertise in engineering, IT, and business economics. They emphasize the "Triple Top Line" approach, which integrates economic returns with environmental and social impact, aligning investments with Sustainable Development Goals (SDGs). MVP's portfolio includes companies like sonnen, a leader in smart energy storage solutions, and Electrochaea, which develops power-to-gas technology for renewable energy storage. Other notable investments are in GreenCom Networks, a provider of IoT solutions for energy management, and Kebony, which offers sustainable wood products to replace tropical hardwoods in construction. By focusing on sustainable innovations, MVP aims to create long-term value while addressing some of the world's most pressing environmental challenges. The firm is committed to supporting visionary entrepreneurs who are developing technologies that contribute to a more sustainable and efficient industrial future.

Mustard Seed VC, founded in 2015 by Henry Wigan and Alex Pitt, is a London-based venture capital firm focusing on impact investments. They back innovative businesses that tackle significant social and environmental challenges. Their investment philosophy emphasizes the "lock-step" approach, where the business model inherently benefits society, aligning with their goal of sustainable capitalism. Mustard Seed VC's portfolio includes notable investments such as What3Words, a geocoding system that improves location accuracy, and Winnow Solutions, which uses technology to reduce food waste. The firm has had successful exits, including Lifecake, a family photo-sharing app acquired by Canon. They typically invest in seed and growth stages, with investment sizes ranging from £100,000 to £500,000, and have the capacity to follow on into Series A rounds. Mustard Seed is committed to long-term partnerships, offering extensive support to their portfolio companies. Mustard Seed's impact-driven approach has attracted support from significant backers like Big Society Capital, enhancing their ability to drive capital towards socially impactful ventures. Their guiding principles include fortitude, persistence, humility, and audacity, which they believe are essential for building transformative businesses​.

MVM Partners, founded in 1997, is a global venture capital firm focused on high-growth healthcare investments. With offices in Boston and London, MVM invests broadly across sectors including medical technology, pharmaceuticals, diagnostics, digital health, and other healthcare-related fields. Their portfolio includes notable companies such as SkyCell, which developed patented temperature-control technology for safely transporting vaccines and biotech drugs, and Ossio, which created OSSIOfiber Intelligent Bone Regeneration Technology—a novel orthopedic fixation material that integrates into native bone and avoids the need for permanent metal implants. MVM also invested in MDxHealth, a company specializing in molecular diagnostics for urologic cancers, which enhances personalized cancer diagnosis and treatment. MVM's investment strategy emphasizes significant minority stakes in innovative companies, providing both financial support and strategic guidance to help these companies grow and scale. Their approach involves close collaboration with management teams to drive business development and market expansion. MVM's recent investments include companies like eXmoor Pharma, which focuses on cell and gene therapy services, and Nalu Medical, which develops minimally invasive solutions for chronic pain management. These investments reflect MVM's commitment to supporting advancements in medical technology and improving patient outcomes globally.

Naspers, based in Cape Town, South Africa, is a global consumer internet group and one of the world's largest technology investors. Its diverse portfolio spans over 100 markets, with significant investments in sectors such as e-commerce, fintech, food delivery, and education technology. Key investments include leading companies like Tencent, Delivery Hero, and Udemy. Naspers has also backed innovative startups such as ElasticRun, a B2B platform, and Immutable, a blockchain infrastructure provider. Their strategy involves identifying high-growth opportunities and leveraging their extensive global network to drive value and scale. Naspers operates through its investment arm, Prosus, and maintains a dual listing on the Johannesburg Stock Exchange and Amsterdam's Euronext. Recently, Fabricio Bloisi, formerly head of iFood, was appointed CEO, succeeding Bob van Dijk. The company is known for its active role in nurturing startups, with notable exits like Zomato and Remitly. For startups, Naspers is a strategic partner, offering not just capital but also operational support to accelerate growth and achieve market leadership. Approaching them typically involves highlighting potential synergies with their existing portfolio and demonstrating robust growth potential​.

NGP Capital, founded in 2005 and headquartered in Palo Alto, California, is a global venture capital firm with a focus on growth-stage technology companies. They have over $1.6 billion under management and invest in sectors such as edge cloud, cybersecurity, digital industry, and digital transformation. Notable investments include Deliveroo, a leading food delivery platform; Moovit, a mobility services company acquired by Intel; and PubMatic, an adtech company that went public in 2020. Other prominent investments are Lime, a scooter rental platform, and Shadowfax, an on-demand hyperlocal delivery service. NGP Capital operates globally, with a significant presence in the U.S., Europe, and Asia. Their portfolio is managed using an AI-powered platform named "Q," which helps identify and rank potential investments based on over 700 growth parameters. The firm is led by experienced partners like Bo Ilsoe, who emphasizes backing ambitious entrepreneurs with a global vision. NGP Capital’s strategy leverages its partnership with Nokia to support portfolio companies with industry insights and market access.

Natural Bridges Ventures (NBV) is a global venture capital firm based in Silicon Valley, specializing in scaling disruptive technologies through a unique blend of strategic guidance and operational acceleration. NBV focuses on early-stage companies that operate at the intersection of communication, collaboration, and technological innovation. With an emphasis on design thinking, the firm partners with startups aiming to transform markets in areas such as IoT, digital health, mobility, and the digital enterprise​. What sets NBV apart is its global network and ability to connect startups with ecosystems across key regions, including the U.S., Europe, Asia, Israel, and Latin America. The firm employs a disciplined, process-oriented approach to ensure rapid market entry and scaling for its portfolio companies. NBV works closely with corporate partners and startups alike, facilitating the integration of external innovation into larger business ecosystems. Their focus on "innovation by design" helps identify untapped opportunities and empower businesses to create lasting, market-shifting solutions​. NBV's portfolio includes high-growth ventures that leverage cutting-edge technologies to address critical challenges across multiple sectors. By nurturing startups with both strategic investment and hands-on operational support, NBV accelerates their journey from concept to commercialization. With a cross-functional team of experienced entrepreneurs and corporate executives, the firm offers both financial and strategic resources, ensuring that their portfolio companies can navigate complex markets and achieve sustained growth on a global scale.

Navigare Ventures, founded in 2021 and based in Stockholm, is an early-stage venture capital firm specializing in science-driven companies. As a subsidiary of Wallenberg Investments AB, Navigare Ventures focuses on deep tech sectors, including advanced computing, quantum technologies, synthetic biology, bio innovation, and data-driven life sciences. The firm is committed to investing in transformative technologies that have a strong industrial and societal impact. Navigare Ventures typically invests in Seed and Series A rounds, partnering closely with founders to support the growth and development of their companies. The firm has a robust portfolio that includes companies like Elypta, a startup developing metabolism-based liquid biopsy technology for cancer detection, and EnginZyme, which focuses on sustainable biomanufacturing. Their investment strategy is characterized by long-term partnerships, leveraging an extensive network of scientific and industrial expertise to help startups scale and succeed in their respective fields​.

Naxicap Partners, a subsidiary of Natixis Private Equity, is a leading French private equity firm managing €6.7 billion in assets as of the end of 2022. The firm focuses on mid-cap buyouts and small-cap growth investments across diverse sectors including healthcare, technology, real estate, and business services. They are known for supporting companies with strong growth potential and stable business models, adapting their investment focus based on sectoral economic dynamics. Notable investments in Naxicap's portfolio include Advanced Accelerator Applications, a developer of molecular nuclear medicine theragnostics, and Alltub, a manufacturer of collapsible aluminum tubes. The firm has also seen successful exits such as the sale of Maxi Bazar to the Zouari family group and House of HR to Bain Capital. Naxicap has a strong commitment to ESG principles, having received the highest rating from the UN Principles for Responsible Investment for Strategy & Governance. They focus on incorporating ESG issues into their investment analyses and ownership policies, promoting sustainability within the investment industry.

NCL Technology Ventures is a UK-based venture capital firm specializing in early-stage investments across the healthcare and life sciences sectors. Founded in 2010, the firm focuses on identifying and backing companies that are driving transformational change in healthcare, with a particular emphasis on innovation in areas such as therapeutics, medical technologies, and digital health. NCL's mission is to foster companies that are developing breakthrough solutions to address global health challenges, from preventive care to cutting-edge treatments​. The firm's investments typically range between €1.5M and €3M, with a strong focus on seed and Series A funding. NCL is deeply involved in the strategic development of its portfolio companies, providing both capital and operational expertise to help them navigate the complexities of the healthcare landscape. The firm's portfolio includes companies like TC BioPharm, which is pioneering allogeneic cell therapies, and Curesponse, a precision medicine startup. With offices in London and the US, NCL is well-positioned to support its portfolio globally, fostering partnerships and driving innovation in both European and American markets. Their team, led by experienced venture capitalists like Jerry Biggs and Jonathan Synett, brings decades of investment and entrepreneurial expertise to the table.

Nesta Impact Investments, the venture capital arm of Nesta, focuses on funding innovative tech ventures that aim to create significant social and environmental impact. The firm, rebranded from Janvest Capital Partners, operates with a clear mission to make the world healthier, fairer, and more sustainable by 2030. Their recent £50 million fund targets startups in sectors like edtech, foodtech, healthtech, climate tech, and the future of work. Nesta's portfolio includes companies such as Bibliu, an educational resource platform; Skin Analytics, an AI tool for skin cancer detection; and Arbor Education, a data and software provider for schools. They have also supported Koru Kids, a tech-enabled childcare platform; Habitual Health, a program for reversing Type 2 diabetes; and Oxford Medical Products, which developed a "gastric balloon in a pill". Nesta's approach involves more than just providing capital. They offer comprehensive support through their vast network, policy knowledge, and expertise in data and behavioral insights, ensuring portfolio companies can scale while maintaining their mission-driven focus. Investments typically range from £500k to £1m for Seed to Series A rounds, with potential follow-up investments of up to £4 million.

NeuHelium is an innovative venture capital firm that focuses on investments in advanced technology sectors, particularly those related to brain-inspired intelligence and AI-based chips. The firm aims to build a robust industrial development engine powered by cutting-edge AI technologies. This approach aligns with their vision of leveraging artificial intelligence to create significant advancements in various industries, ensuring a transformative impact on the market. NeuHelium specializes in providing early-stage financing, helping startups develop from initial concepts to viable products. Their investment strategy is centered on high-growth potential startups that exhibit strong market demand and innovative solutions. By offering seed financing, NeuHelium supports startups in conducting market research, developing prototypes, and covering essential operational expenses. This high-risk investment strategy is balanced by the potential for substantial returns if the startups succeed, much like other venture capital funds that focus on early-stage investments​.

Neulogy Ventures, established in 2014 and based in Bratislava, Slovakia, is a Luxembourg-regulated venture capital fund. The firm focuses on early-stage tech companies, particularly those operating in Slovakia and the Central and Eastern Europe (CEE) region. Neulogy Ventures manages €65 million in assets, with a diverse portfolio spread across 10 countries. The fund targets investments in sectors like media, cleantech, data analytics, productivity applications, medtech, infrastructure, fintech, security, 3D, e-commerce, and new energy. Neulogy Ventures aims to support mission-driven entrepreneurs with bold ideas that push technological frontiers, particularly those addressing climate change and healthcare challenges. Neulogy Ventures emphasizes a hands-on approach, offering strategic guidance, business development support, and fundraising assistance to its portfolio companies. The firm values long-term partnerships, prioritizing shared values and a collaborative approach over quick exits. Notable companies in Neulogy's portfolio include GA Drilling, GreenWay, and GroupSolver. The team, led by managing partners Christian Mandl and Jaroslav Luptak, brings extensive experience in entrepreneurship, fundraising, and business development, ensuring robust support for their investees.

Neva SGR, founded in 2020, is the venture capital arm of Intesa Sanpaolo Group, one of Italy's largest banking institutions. Based in Turin, Neva focuses on investing in technology-driven companies at various stages, from seed to Series C. The firm is sector-agnostic but leans heavily towards fintech, deeptech, ESG transition technologies, and core tech innovations. With two main funds—Neva First and Neva First Italia—the firm targets both Italian and international startups. Neva First focuses on global opportunities, with a minimum of 30% invested in Italian companies, while Neva First Italia co-invests with a more localized emphasis on Italian startups. The funds have a combined budget of around €500 million, with an average ticket size of €4-10 million per investment. Neva SGR is particularly active in life sciences and deeptech, with notable portfolio companies including D-Orbit in space logistics and Tr1X, a biotech firm focused on autoimmune therapies. The firm’s mission is to foster innovation that addresses global challenges while boosting the Italian and European tech ecosystems.

NAV.VC, formerly known as New Atlantic Ventures, is a venture capital firm based in Reston, Virginia. Founded in 1999, the firm has a strong focus on investing in seed and early-stage companies, particularly those operating in the technology sector. NAV.VC’s investment strategy centers around emerging and disruptive consumer trends, with key sectors including cybersecurity, digital health, fintech, e-commerce, education technology, and advertising technology. The firm is known for its hands-on approach, working closely with portfolio companies to help them navigate the challenges of early growth and scale their operations effectively. NAV.VC leverages its extensive network and deep industry expertise to provide strategic guidance, mentoring, and support to its portfolio companies, aiming to drive their success in highly competitive markets. NAV.VC’s portfolio features a diverse range of companies that are at the forefront of innovation in their respective fields. The firm has a track record of identifying promising startups with the potential to disrupt traditional industries and create significant value for both customers and investors. By investing in companies that align with emerging market trends, NAV.VC positions itself as a forward-thinking venture capital firm that is deeply committed to fostering innovation and supporting the next generation of tech entrepreneurs.

VisVires New Protein, recently rebranded as Clay Capital, is a Singapore-based venture capital firm dedicated to transformative investments in the agrifood tech sector. Founded in 2014, Clay Capital focuses on supporting innovative startups that address fundamental challenges in the food system, particularly in the areas of sustainable packaging, fermentation, agricultural biologicals, crop disease resistance, soil health, and regenerative agriculture. Notable investments include French biostimulant producer Toopi, Israeli bioherbicide startup WeedOUT, and French kitchen robot manufacturer Cook-e. These investments reflect Clay Capital's commitment to leveraging technology to improve sustainability and efficiency in the food and agriculture sectors. Clay Capital's strategy involves investing in early-stage to growth-stage startups, typically with initial checks ranging from $3 million to $8 million, and reserving additional capital for follow-on investments. The firm serves as a bridge between the Asian and European markets, providing startups with support to access and expand in these regions. The rebranding from VisVires New Protein to Clay Capital signifies a renewed focus on building a healthy and sustainable food system, symbolizing fertile ground for growth and innovation. With a newly raised $145 million fund, Clay Capital is well-positioned to continue driving impactful changes in the agrifood tech landscape

NewSpace Capital is a space-focused venture capital firm that invests in growth-stage companies at the intersection of space technology and sustainable development. With a focus on scalable technologies and established revenues, NewSpace targets businesses that leverage space applications to address critical global challenges, including climate change, environmental monitoring, and resource management. The firm typically invests between €10 to €20 million in companies that are ready to scale their operations, offering both financial support and strategic expertise. NewSpace Capital operates with a “picks & shovels” strategy, concentrating on key areas like satellite communications, earth observation, remote sensing, advanced analytics, and space infrastructure. Their approach minimizes risk by backing companies that have moved beyond technical and market entry barriers, ensuring they are poised for significant growth. Portfolio companies like ICEYE, which specializes in Synthetic Aperture Radar (SAR) technology for earth observation, and Kayrros, a leader in environmental intelligence, highlight NewSpace’s commitment to leveraging space technology for tangible impacts on Earth. The firm is led by a team of multidisciplinary experts with deep industry connections, allowing them to access exclusive deals in underinvested segments of the space market. With a target fund size of €250 million, NewSpace Capital aims to drive the next wave of innovation in space while addressing pressing global issues, positioning itself as a key player in the rapidly expanding space economy.

NewSpring Capital, founded in 1999 and headquartered in Radnor, Pennsylvania, is a private equity firm focusing on growth equity, mezzanine capital, healthcare, and buyouts. The firm manages approximately $3.5 billion in assets and has invested in over 250 companies across various sectors. Notable investments in NewSpring's portfolio include Vacasa, a leading vacation rental management company; Innovid, a video marketing platform; and Nutrisystem, a weight management company. These investments reflect NewSpring's strategy of supporting high-growth companies in business services, healthcare, information technology, and consumer products. NewSpring Capital operates through multiple strategies, including NewSpring Growth, which targets high-growth technology companies; NewSpring Healthcare, focusing on innovative healthcare services and technology; and NewSpring Mezzanine, providing capital for acquisitions and recapitalizations. The firm's comprehensive approach allows them to support companies at different stages of their lifecycle, from early growth to expansion.

New Venture Partners is a global venture capital firm that specializes in transforming corporate R&D assets into standalone businesses. The firm focuses on leveraging cutting-edge innovations from large technology companies and spinning them out into independent ventures. With a unique approach, New Venture Partners works closely with corporate partners to identify high-potential technologies that may not align with the company's core business but have significant market opportunities. The firm invests primarily in sectors such as telecommunications, IT, semiconductors, and digital media, emphasizing deep tech and transformative innovations. Their portfolio includes companies that emerged from major R&D labs, such as Bell Labs and British Telecom, showcasing their expertise in corporate spinouts. New Venture Partners typically invests in early-stage startups, guiding them from the incubation phase through to commercialization. Their team brings a wealth of experience from both the corporate and entrepreneurial worlds, providing a mix of strategic guidance and operational support to help ventures scale. With offices in the U.S. and Europe, New Venture Partners has a global reach and focuses on markets across both continents. Their strategy revolves around aligning with corporate partners to unlock the commercial potential of underutilized technologies, ultimately creating high-value businesses that deliver strong financial returns. The firm has established a reputation as a leader in corporate venture capital, with a track record of successful exits and long-term value creation.

New Wave Ventures is a dynamic, privately-owned venture capital fund based in London. Focused on investing in companies with significant growth potential, New Wave targets initial investments ranging from £500,000 to £2,000,000. Unlike many funds, New Wave Ventures invests its own capital without relying on external investors, allowing for a more flexible and long-term investment approach. Their investment philosophy centers on the belief that great businesses are built by great people. New Wave Ventures seeks entrepreneurs who can overcome obstacles and dominate their markets on a global scale. They prefer to co-invest with like-minded partners but often opt to be the sole investor alongside committed owner-managers. This fund is not driven by short-term exits or leverage; instead, it focuses on sustainable growth and strategic support​. Geographically, New Wave Ventures concentrates on the UK, particularly the North West region, encompassing cities like Manchester and Liverpool. Their goal is to fill the funding gap for early-stage and scale-up businesses in these areas, fostering innovation and growth​. The leadership team at New Wave brings a wealth of experience in running successful businesses and tackling various challenges. Their approach involves minimal interference in day-to-day operations, instead offering strategic guidance and financial support. Startups can reach out directly via email for potential investment opportunities​. This combination of substantial financial backing, strategic expertise, and a people-first philosophy makes New Wave Ventures a compelling partner for ambitious entrepreneurs looking to scale their businesses.

Newfund Capital, founded in 2008, is an entrepreneurial venture capital firm with a strong presence in both Paris and Silicon Valley. With $300 million in assets under management, Newfund focuses on seed-stage startups driving global change. Notable investments include Aircall, Fairmoney, and In2Bones, showcasing their diverse and impactful portfolio. The firm invests primarily in technology, precision medicine, personalized treatment, and brain tech sectors. They emphasize early-stage investments, aiming to support startups from the seed stage through international expansion, particularly in France and North America. Newfund's strategy involves quick decision-making, often providing term sheets within three weeks. They seek entrepreneurs with a global mindset and provide significant value beyond capital, including scaling opportunities, networking, and strategic support. The average check size varies but is tailored to meet the needs of each startup, with Newfund often leading the investment rounds. The team includes key members like Henri Deshays and Patrick Malka, who bring extensive entrepreneurial and investment experience. The team is split between their Paris and Palo Alto offices, allowing them to maintain a strong presence in both Europe and the U.S. For startups looking to scale rapidly with a partner who understands the entrepreneurial journey, Newfund Capital offers a compelling blend of expertise, resources, and strategic guidance.

Newion is a pan-European early-stage venture capital firm based in Amsterdam, specializing exclusively in business software. Since its founding in 2000, Newion has invested in over 60 startups, helping companies like Collibra, Deliverect, and Foleon emerge as market leaders in their sectors. Their primary focus is on innovative B2B software companies within the Benelux, Nordics, and Germany. Newion's investment strategy involves participating in seed rounds and Series A funding, providing both capital and hands-on support to help startups scale. The firm manages a total of €300 million in assets across several funds, with their latest, Newion IV, launching with an initial closing of €130 million. The Newion team includes seasoned professionals such as Patrick Polak and Frank Claassen, who bring extensive experience in venture capital and corporate finance. Their approach is characterized by a no-nonsense mentality and a deep commitment to helping their portfolio companies achieve significant growth and market leadership.

Newton Biocapital is a Brussels-based venture capital firm with a strong presence in both Europe and Japan, focusing exclusively on the life sciences sector. Established in 2017, the firm’s investment strategy is centered on supporting companies that tackle chronic diseases, with an emphasis on oncology, metabolic diseases, and neurological conditions. Newton Biocapital plays a hands-on role in its portfolio companies, often leading funding rounds and taking board positions to guide scientific and clinical strategies​. The firm manages two funds—Newton Biocapital I (€114M) and Newton Biocapital II, which is currently targeting €150M. NBC I invested in 14 companies across Europe and Japan, including university spin-offs like Epics Therapeutics and ChromaCure in Belgium, and biotech firms like EditForce in Japan. Newton's approach is deeply integrated with the local ecosystems in both regions, leveraging their strong ties to academic institutions, industry experts, and international investors to facilitate cross-border growth and exits​. Newton’s team combines scientific, regulatory, and investment expertise, led by CEO Alain Parthoens. With offices in Brussels and Tokyo, they are uniquely positioned to bridge the innovation pipeline between Europe and Japan, driving impactful advancements in life sciences​.

Credit Suisse Entrepreneur Capital Ltd., established in 2010, is the venture capital arm of Credit Suisse based in Zurich, Switzerland. The firm focuses on investing in innovative small and medium-sized enterprises (SMEs) and startups across various sectors, including robotics, automation, medtech, and fintech. To date, Credit Suisse Entrepreneur Capital has invested around CHF 130 million in over 50 companies, and recently expanded its fund by an additional CHF 70 million, bringing the total to CHF 200 million. Notable investments from Credit Suisse Entrepreneur Capital include Perspective Robotics (d.b.a. Fotokite), a Zurich-based startup specializing in tethered drones that improve the safety and efficiency of public safety operations, and Ava, a company in the monitoring equipment sector. These investments highlight the firm’s commitment to supporting high-potential technologies and innovative business models. Credit Suisse's venture capital efforts are part of a broader strategy to support Switzerland's entrepreneurial ecosystem, ensuring the country remains a global leader in innovation and business. For more information about their investments and strategic approach, you can visit their official website.

NextWorld Capital, founded in 2009 and headquartered in San Francisco, is a venture capital firm that invests in early to growth-stage companies, particularly focusing on enterprise software, analytics, fintech, and telecommunications sectors. The firm is renowned for its hands-on approach in helping startups scale, often participating in follow-on rounds to support ongoing growth. Notable investments in NextWorld Capital's portfolio include Aircall, a cloud-based voice platform for managing customer support and sales calls; Stampli, an AI-driven AP automation company; and Honeycomb, which provides analytics and observability tools for software developers. Other significant investments are Spiff, a sales commission software, and Routefusion, a fintech company specializing in cross-border payments. The firm is known for its collaborative investment approach, often co-investing with other prominent venture capital firms to maximize the potential of its portfolio companies. NextWorld Capital has successfully nurtured numerous startups to significant growth stages, ensuring they achieve their full potential through strategic guidance and resources.

ND Capital, formerly known as NanoDimension, is a venture capital firm established in 2002, headquartered in Woodside, California. The firm focuses on investing in disruptive technologies across the life sciences, physical sciences, and data sciences sectors. Their core belief is that significant breakthroughs will arise from the convergence of these scientific disciplines. The firm is led by founder and CEO Aymeric Sallin, who has been pivotal in steering the company towards successful investments. ND Capital supports early to mid-stage companies, particularly those developing innovative and market-disruptive technologies. Their investment strategy targets companies at the forefront of scientific advancements that hold the potential to create substantial impact. ND Capital's diverse portfolio includes investments in companies like Natron Energy, Tarveda Therapeutics, Selecta Biosciences, and SQZ Biotech. The firm has a strong track record with numerous successful exits, such as the acquisition of Serotiny by Johnson & Johnson and Icosavax's IPO. The team at ND Capital consists of experienced professionals with deep expertise in various scientific and industrial fields. This includes Senior Partner Patrick Aebischer, who has extensive experience in biotechnology and academic leadership, and Partner Eric Moessinger, who focuses on life sciences investments. ND Capital's mission is to back visionary founders and innovative startups that push the boundaries of science and technology, driving forward transformative solutions that address global challenges..

Nina Capital is a specialized venture capital firm based in Barcelona, focusing on early-stage investments in health technology. Founded by Marta Gaia Zanchi, the firm invests across Europe, the United States, Canada, Israel, and Australia. Nina Capital leverages the Biodesign process from Stanford, which emphasizes a need-driven and value-based approach to healthcare innovation. Their investment strategy spans pre-seed to seed stages, with typical investment sizes ranging from €200k to €1.5m​. The firm supports startups that apply advanced data science, engineering innovation, and IT-enabled products to solve healthcare challenges. Notable portfolio companies include QuantHealth, which uses AI to predict patient responses in clinical trials, and Cardiomatics, offering automated ECG interpretation to improve healthcare efficiency​. The core team, led by principals like Anastassiou and Yahel Halamish, combines deep expertise in healthcare, technology, and investment. They are committed to diversity and multidisciplinary collaboration, fostering an inclusive environment that promotes innovative solutions to complex healthcare problems.

NGP Capital, founded in 2005, is a venture capital firm based in Palo Alto, California. The firm has a significant global presence with offices in Berlin, Helsinki, and Geneva, and focuses on early growth investments in B2B sectors such as cybersecurity, industrial technology, deep tech, robotics, supply chain, and data infrastructure. NGP Capital typically invests $10-15 million in the first round, aiming for a 10-15% ownership stake and an active role in their portfolio companies. The firm manages over $1.6 billion in assets and uses a proprietary AI-powered platform, "Q," to identify and evaluate investment opportunities globally. This system scans and ranks more than 2 million companies, helping NGP make data-driven investment decisions. NGP Capital has invested in more than 100 companies, with notable exits including UC Mobile, acquired by Alibaba for $3.8 billion, and Ganji, acquired by 58.com for $3.6 billion. Other significant portfolio companies include PubMatic, Deliveroo, and Moovit. Their investments are geographically diverse, with 27% in Europe, 38% in the US, and 35% in Asia. The firm continues to leverage its partnership with Nokia, focusing on strategic investments that align with Nokia's innovation framework around 5G and related technologies. This partnership allows NGP Capital to combine financial discipline with technological insights, driving growth and strategic value in their portfolio.

NOON Ventures is a Copenhagen-based early-stage venture fund, launched in 2020 by Caspar Høgh and Theis Malmborg. The fund focuses on investing in transformative technologies that tackle environmental and climate challenges. With a hands-on approach, NOON Ventures works closely with its portfolio companies, acting as co-developers to support long-term growth. Their sectors of interest include biotech, clean energy, manufacturing, and sustainability, specifically targeting companies in Northern Europe. The fund typically leads or co-leads investments, with check sizes ranging from €2-5 million. Its notable investments include Spectro Inlets, Enduro Genetics, and Lotus Microsystems, all working on innovative solutions in sustainability and tech. NOON Ventures emphasizes its commitment to limiting the number of investments, ensuring they can deeply engage with each startup across strategy, talent acquisition, and customer growth. NOON Ventures has made sustainability central to its mission, and its investments align with this philosophy, aiming to contribute to the UN's Sustainable Development Goals. Entrepreneurs with proven technology and a passion for environmental impact will find an ideal partner in NOON Ventures, especially if they seek more than just financial backing.

Nordic Alpha Partners (NAP) is a Copenhagen and Munich-based growth equity fund specializing in scaling industrial GreenTech companies. Established in 2017, NAP manages over €275 million across its funds, focusing on helping visionary founders expand their operations from local players to global leaders. The firm’s unique operational approach emphasizes active engagement, with partners working closely with portfolio companies for up to a year before formal investment. This de-risks ventures and supports rapid, capital-efficient growth. NAP's investment strategy is rooted in sustainability, specifically targeting “dark green” companies that contribute to the global green transition. NAP's impact is demonstrated by the abatement of over 1.1 million tonnes of CO2 and the creation of more than 700 jobs across its portfolio. Notable investments include AquaGreen, which revolutionizes biomass pyrolysis for energy and nutrient recovery, and Green Hydrogen Systems, a leader in the green hydrogen revolution. With strong backing from investors like Allianz Global Investors, Novo Holdings, and KfW Capital, NAP has emerged as a leader in the GreenTech space. Their approach is supported by an extensive value-creation toolkit, which guides companies through the complexities of scaling capital-intensive technologies. NAP also fosters future GreenTech leaders by collaborating with academic institutions, including the Technical University of Denmark. Committed to economic sustainability, NAP helps fuel the growth of next-generation companies that drive the global green transformation while ensuring long-term financial success for their investors.

Nordic Eye Venture Capital is a Danish venture and growth capital firm headquartered in Copenhagen, with additional presence in San Francisco and Zurich. Founded in 2016, Nordic Eye focuses on investing in early-growth companies within the tech and lifestyle sectors. The firm is known for its strategic investments in high-potential companies that have demonstrated product-market fit and scalability. Notable investments in their portfolio include MATE, a company revolutionizing the e-bike market; Bellabeat, a health tech company; and AirHelp, which assists air passengers in claiming compensation for delayed flights. Other significant investments are in companies like Blue Ocean Robotics, known for developing service robots, and Organic Basics, a sustainable fashion brand. Nordic Eye's investment strategy involves not just providing capital but also actively supporting their portfolio companies through their growth stages. They prefer to enter investments once a company has proven its product-market fit and aim to exit when the company has demonstrated its scalability​. The firm is committed to responsible investing, integrating Environmental, Social, and Governance (ESG) policies with their business strategy to ensure sustainable business practices that lead to long-term success​.

NFT Ventures, established in 2014 and based in Stockholm, is a prominent venture capital firm specializing in fintech investments. The firm has carved out a niche within the Nordic fintech ecosystem, backing startups that are transforming the financial industry through innovative technologies. NFT Ventures focuses on a broad range of fintech verticals, including regtech, insurtech, and more, investing in companies that have significant scalability and growth potential. NFT Ventures is an active investor, often taking board seats to provide strategic guidance and operational support to its portfolio companies. The firm has built a diverse portfolio of around 40 companies, including notable names like Gimi, a financial education app for children, and Lunar, a modern digital bank. Their approach extends beyond mere financial investment; they leverage their extensive network and deep industry expertise to help their portfolio companies succeed. With a strong presence in Northern Europe, NFT Ventures is well-positioned to continue driving fintech innovation across the region.

Nordic Makers, established in 2016, is an early-stage investment firm founded by a group of experienced angel investors from the Nordic region. The firm focuses on seed and early-stage investments, primarily in technology-driven startups across the Nordics and Europe. Their investment philosophy centers on providing founder-friendly terms and leveraging their extensive network to support entrepreneurial growth. Notable investments by Nordic Makers include Labster, a leading provider of virtual science labs; Seaborg Technologies, which is developing sustainable nuclear reactor technology; and NextMind, which creates brain-sensing wearable devices for real-time device control. Other significant investments include Willa Pay, Helix Nano, LetsBuild, Singa, and Climateview​. The firm’s founding partners, such as Klaus Nyengaard, Esben Gadsbøll, and Alexander Aghassipour, bring a wealth of experience from successful ventures like Just Eat, WhiteAway, and Zendesk. They focus on fostering cross-border investments and integrating the Nordic and Baltic startup ecosystems.

Norrsken VC is a prominent European venture capital firm focused on impact investing, founded in 2017 in Sweden. The firm supports startups that address significant global challenges while aiming for substantial financial returns. Norrsken VC specializes in sectors such as climate tech, energy, biotech, AI, and health tech, ensuring each investment aligns with the UN Sustainable Development Goals (SDGs)​​. Norrsken VC's portfolio includes high-impact companies like Northvolt, a battery manufacturer; Einride, which develops electric autonomous transport; and 1KOMMA5°, focused on sustainable energy solutions. These companies exemplify Norrsken's commitment to backing startups that positively impact both people and the planet​. The firm recently closed its second fund at €320 million, surpassing its original target of €250 million, making it the largest early-stage generalist impact fund in Europe. This fund is supported by major institutional investors, including Folksam, AP1, and the European Investment Fund (EIF), and aims to empower "force of nature" founders to create impact unicorns​. Norrsken VC's team comprises experienced venture capitalists and industry experts, including General Partners Niklas Adalberth, Tove Larsson, Agate Freimane, and David Frykman. The team is dedicated to finding visionary founders across Europe who share their passion for creating a better future through innovative solutions​.

North Bridge Venture Partners, founded in 1994 and based in Wellesley, Massachusetts, is a venture capital firm that provides seed-to-growth financing. The firm focuses on several key sectors, including communications and infrastructure, software, materials, healthcare, and digital media. North Bridge Venture Partners supports companies from their initial stages through to becoming market leaders, leveraging a combination of operational experience and strategic guidance​. The firm has made over 479 investments and has achieved 183 exits. Notable portfolio companies include Couchbase, Markforged, and Lyra Therapeutics. North Bridge has a significant presence in the U.S. market, focusing primarily on early-stage and growth-stage companies operating in healthcare and information technology sectors​. North Bridge is led by a team of experienced professionals, including founder and managing partner Edward Anderson and general partners Richard D'Amore and Jeffrey McCarthy. The firm's strategy emphasizes investing in exceptional entrepreneurs whose ideas have the potential to disrupt their respective industries.

The North West Fund is a £155 million investment fund aimed at supporting small and medium-sized enterprises (SMEs) in the North West of England. Managed by North West Business Finance Limited, an independent private sector company, the fund was established to address gaps in lending, venture capital, and private equity markets. The fund has been fully invested, supporting over 443 businesses and creating more than 6,300 jobs in the region. The fund comprises several sub-funds, each managed by different fund managers, providing a range of financial support from equity investments to loans. These sub-funds include The North West Fund for Venture Capital, Mezzanine, Loans Plus, Micro Loans, Energy and Environmental, Biomedical, and Digital and Creative. These funds have been instrumental in facilitating the growth and expansion of innovative businesses across various sectors. The North West Fund has a strong team of experienced professionals, including Cliff Maylor (Chief Executive Officer), Neil Morrey (Chief Operating Officer), and Mike Kenyon (Chief Financial Officer). The fund's governance is supported by an independent Board and an Investment Advisory Panel with expertise in private equity, venture capital, and the targeted sectors.

Northern Gritstone is a venture capital firm established in 2020, focused on commercializing cutting-edge science and technology emerging from the North of England. With headquarters in Manchester and strong ties to the Universities of Manchester, Leeds, and Sheffield, Northern Gritstone primarily invests in early-stage companies that originate from these institutions or are based in the region. The firm manages a substantial fund, recently closing at £312 million, to support startups in sectors like deep technology, life sciences, healthcare, and advanced materials. Northern Gritstone's investment strategy is driven by a philosophy of "profit with purpose," aiming to generate financial returns while also contributing to the economic development of the North of England. Northern Gritstone has already made significant investments in companies such as Optalysys, a photonic chip firm, and AssetCool, which develops advanced coatings for industrial applications. The firm is committed to fostering a tech ecosystem in the region, aspiring to create a "Silicon Valley of the North" by backing visionary companies with strong intellectual property and high growth potential.

Northstar Ventures is a UK-based venture capital firm focused on early-stage investments that create a positive social or environmental impact. With a portfolio that spans tech innovation and social enterprises, the firm emphasizes sectors like climate tech, biotech, and healthy aging. Their notable investments include Newcells Biotech, which develops in vitro organ models for drug testing, and NunaBio, a leader in DNA synthesis technology crucial for personalized medicine and data storage solutions​. Geographically, Northstar Ventures primarily focuses on startups in the North East of England but also supports businesses across the UK. They invest through funds such as the North East Innovation Fund and the Northstar EIS Growth Fund, with typical early-stage investments ranging from £300,000 to £1 million​. Their hands-on approach includes extensive support for founders, particularly in sectors that align with sustainability goals, like Low Carbon Materials, which develops environmentally friendly construction materials. Northstar also backs social impact ventures, such as Coping with Cancer North East, reflecting their commitment to community well-being alongside technological innovation.

Northzone, established in 1996, is a multi-stage venture capital fund investing in companies from Seed to Growth stages across Europe and the US. With a notable portfolio that includes companies like Spotify, Klarna, Trustpilot, and Kahoot!, Northzone has built a reputation for backing category-defining entrepreneurs. In 2022, Northzone raised €1 billion, emphasizing its commitment to supporting innovative startups that can thrive amidst global challenges. The firm’s investment strategy spans various sectors, including fintech, healthtech, SaaS, and consumer technology. Northzone typically writes checks between €1 million and €40 million, allowing them to support companies through multiple stages of growth, from initial funding to pre-IPO. Their approach is characterized by a focus on founders with conviction, a willingness to embrace risk, and a dedication to long-term partnerships. Northzone’s team operates across major cities like New York, London, Stockholm, Amsterdam, and Berlin, reflecting their "glocal" (global and local) mindset. This diverse and international team, comprising 36 members from 16 nationalities, brings a wealth of experience and a strong network to the table. The firm values integrity, results, intellectual curiosity, and strong partnerships, and has consistently championed diversity and inclusion both within their team and across their portfolio. Entrepreneurs interested in partnering with Northzone are encouraged to present bold ideas with substantial market potential. The firm values straightforward communication and prefers to invest in teams capable of navigating and thriving in challenging environments

Notion Capital, founded by seasoned SaaS entrepreneurs, excels in investing in early-stage European startups, particularly in SaaS and enterprise tech. With a strong operational background, they leverage deep industry knowledge to support portfolio companies like GoCardless, Paddle, and Mews. Their focus spans business software, fintech, and future finance sectors, targeting transformative technologies like AI and cloud computing. Geographically, Notion Capital is centered on Europe, emphasizing markets in the UK, Germany, and France. Their strategy involves providing significant support through a dedicated platform team, aiding in product development, go-to-market strategies, and talent acquisition. They employ advanced AI for investment sourcing, ensuring they stay ahead in identifying high-potential startups. The fund typically leads Series A rounds, with an average check size of around €15 million, maintaining a portfolio of about 20 core investments. Recent notable investments include Bound, DataOps, and Resistant AI. Founders benefit from Notion's extensive network and strategic guidance, fostering growth and scaling efficiently. Key team members include Stephen Chandler, Jos White, and Itxaso del Palacio, who bring extensive experience from their entrepreneurial and investment backgrounds. This diverse and dynamic team is committed to a hands-on approach, driving success and innovation within their portfolio companies. Overall, Notion Capital stands out for its founder-friendly approach, combining strategic insights with robust financial backing, making it a formidable player in the European venture capital landscape.

New Venture Fund (Norwest Venture Partners) is a leading venture capital and growth equity investment firm with a diversified investment strategy. It focuses on early- to late-stage investments across various sectors, including consumer, enterprise, and healthcare. Norwest has a robust global presence with offices in North America, India, and Israel, enabling it to identify and support innovative companies worldwide. Notable investments by Norwest include companies like Dave, Gong, Swiggy, Udemy, Vuori, and Ritual. These investments demonstrate the firm's commitment to backing visionary leaders and transformative businesses. Norwest’s investment strategy includes providing not only capital but also strategic guidance and operational support to help portfolio companies scale and achieve significant growth. The firm has recently launched its $3 billion fund, NVP XVI, to continue empowering high-impact businesses. In recent years, Norwest has expanded its focus within the healthcare sector to include biotechnology, building on its successes in medical devices, diagnostics, and healthcare services. Norwest's notable exits include companies such as Opendoor, Talkspace, Udemy, Aporeto, CyberX, and Shape Security, among others. The firm is also committed to environmental, social, and governance (ESG) principles, investing in companies that prioritize sustainability and social impact​.

Novo Holdings is a premier life sciences investment firm based in Copenhagen, Denmark, with additional offices in Boston, San Francisco, London, and Singapore. The firm is wholly owned by the Novo Nordisk Foundation and manages an extensive portfolio aimed at generating long-term returns while advancing health and sustainability. Novo Holdings focuses on investments across biotechnology, medical technology, and digital health sectors, supporting companies at various stages, from early development to commercial phases. In 2023, the firm deployed DKK 3.6 billion, including significant investments in 4D Molecular, Alentis Therapeutics, and Lexeo Therapeutics. The firm's strategy emphasizes innovation in patient care and strong financial returns. Notably, Novo Holdings operates with an evergreen fund structure, allowing a long-term perspective on its investments. The firm actively engages with portfolio companies, often taking board positions to leverage its vast network and expertise. The investment team, led by Managing Partner Scott Beardsley, comprises professionals across major life science hubs. Key team members include Amit Kakar, Head of Novo Holdings Asia, and Anna Fan, Senior Partner in the Life Sciences Operating Committee. For startups seeking investment, Novo Holdings values groundbreaking science and robust clinical data, favoring companies with late preclinical or clinical stage compounds in biotech, and commercial stage entities in medtech and digital health

NP-Hard Ventures is an early-stage venture capital fund based in Amsterdam, Netherlands, focused on investing in product-obsessed founders. The firm targets pre-seed and seed stage startups in Europe and the US, particularly those building infrastructure, tools, and decentralized platforms that simplify and enhance productivity. Founded in 2021 by Anke Huiskes, Micha Hernandez van Leuffen, and Paul Veugen, NP-Hard Ventures has raised €12 million in its inaugural fund, exceeding their initial target of €10 million. The fund plans to invest average checks of €250,000 into around 20 startups, reserving 25% of the fund for follow-on investments. Their portfolio includes innovative companies like Tldraw, an open-source drawing tool for software design, and Emidat, a platform aimed at reducing emissions in the construction industry. The firm is particularly interested in software startups with technical founders who are developing enterprise solutions​. NP-Hard Ventures is distinguished by its operational experience, with the founders having collectively invested in over 50 early-stage companies and 15 funds across Europe and the US. The team aims to bring a sense of urgency and competitive edge from their experiences in the San Francisco tech scene to the European startup ecosystem​.

Nucleus Capital, founded in 2020 and based in Berlin, Germany, is a venture capital firm dedicated to supporting early-stage, purpose-driven entrepreneurs tackling systemic challenges to planetary health. They focus on three main sectors: programmable biology, food technology, and green industrials. Notable investments by Nucleus Capital include Yuri, a space biotech company; Planet A Foods, which develops biotech-derived food ingredients; and Hier Foods, a digital platform for food distribution. Other key investments encompass innovative startups like Farmless, which transforms renewable energy into food, and Brineworks, which focuses on ocean-based CO2 removal through electrochemistry​. Nucleus Capital typically invests in pre-seed and seed stages with check sizes ranging from €150k to €1 million. They aim to partner with mission-driven teams possessing deep domain expertise and creative solutions to global environmental challenges​​. The firm is led by co-founders Maximilian Schwarz and Isabella Fandrych, who bring significant expertise and a strong commitment to fostering entrepreneurial innovation for planetary health​.

Nutreco is a global leader in animal nutrition and aquafeed, committed to sustainably feeding the growing global population. Headquartered in the Netherlands, Nutreco operates through two primary business lines: Skretting, which focuses on aquaculture, and Trouw Nutrition, which serves the livestock industry. The company’s overarching mission, known as "Feeding the Future," is to drive sustainability across the entire food production chain. Nutreco's strategy is centered around three main areas: supporting sustainable production through technology, advancing nutrition and animal health, and sourcing future protein ingredients. The company is heavily invested in developing sustainable alternatives to traditional feed ingredients, including the use of insect protein and other novel sources. This approach aims to reduce the environmental footprint of animal farming, which is crucial as feed ingredient production currently accounts for a significant portion of greenhouse gas emissions in the livestock industry. Innovation is a key pillar of Nutreco's operations, primarily driven by their NuFrontiers team, which focuses on breakthrough technologies that can transform the protein value chain. Nutreco has also been expanding its production capabilities in growth markets like Asia and Latin America, as well as optimizing its operations to increase agility and reduce costs. The company’s investments are aimed at not just expanding its market presence but also ensuring that its products and practices are aligned with global sustainability goals, making it a crucial player in the future of food production​.

Nysnø Climate Investments is a state-owned Norwegian venture capital fund focused on advancing climate solutions through smart, profitable investments. Established in 2017 and based in Stavanger, Nysnø targets companies and technologies that directly contribute to reducing greenhouse gas emissions. The fund invests across sectors such as renewable energy, battery technology, offshore wind, and sustainable materials, supporting companies in their growth and commercialization phases. Nysnø has made significant strides in the green industry, with notable investments in companies like Morrow Batteries, a leader in sustainable battery production, and Vårgrønn, which develops offshore wind projects. The fund also emphasizes the importance of building new green value chains and has recently expanded into international investments, including participation in ArcTern Ventures II, a cleantech fund with a focus on North America and Europe. Primarily investing in companies linked to Norway, Nysnø also places a strong focus on long-term profitability, ensuring that its investments yield both financial returns and substantial environmental benefits. Through its portfolio, Nysnø has contributed to the growth of over 185 companies, helping to accelerate the green transition while creating positive societal impacts.

Oak Investment Partners is a leading multi-stage venture capital firm that focuses on high-growth opportunities across several sectors, including information technology, financial services technology, healthcare, and clean energy. Founded in 1978, Oak has invested over $9 billion in more than 525 companies worldwide. The firm is known for its hands-on approach, offering comprehensive support and strategic assistance through its extensive network of industry experts. Oak's portfolio includes notable companies such as Castlight Health, Zayo Group, Kayak, Benefitfocus, and Protean Electric, among others. Their investment strategy spans early to late-stage investments, including growth equity and PIPE (private investment in public equity) investments. Oak Investment Partners has built a reputation for its ability to identify transformative opportunities and support them through long-term, steady guidance​. The firm is headquartered in Norwalk, Connecticut, with additional offices in California. The team includes experienced professionals like Managing Partners Bandel Carano, Ed Glassmeyer, Fred Harman, and Ann Lamont, who bring deep domain expertise and a consistent investment philosophy to the table​.

Ocean 14 Capital is a private equity firm dedicated to transforming the "blue economy," with a strong focus on addressing environmental challenges while generating competitive financial returns. Established in 2020, the firm primarily invests in sectors like sustainable aquaculture, alternative proteins, circular plastics, and ocean conservation technologies. Its mission aligns with the United Nations’ Sustainable Development Goal 14 (SDG 14), which aims to conserve and sustainably use ocean resources​. The firm has successfully raised €200 million for its first fund, attracting cornerstone investors such as the European Investment Fund (EIF), Minderoo Foundation, and Chr. Augustinus Fabrikker. Ocean 14’s investment strategy targets companies with innovations that protect marine ecosystems and promote food security, such as SyAqua (shrimp genetics and nutrition) and AION (a circular plastics service)​. Ocean 14 seeks to drive sustainable growth in the blue economy, a sector expected to reach $3 trillion by 2030. They aim to invest in 20-25 companies, with an emphasis on scalable technologies that offer both environmental impact and financial returns​.